Liu, Huixian

Publications

Sort by

Co-Author Network

Anti-tumor effect of novel cationic biomaterials in prostate cancer. Anticancer research. 2014 Academic Article GET IT
Times cited: 15
Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse model. Journal of oncology. 2012 Academic Article GET IT
Times cited: 16
Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia. The American journal of pathology. 2009 Academic Article GET IT
Times cited: 50
Antitumor effects of an imidazoquinoline in renal cell carcinoma. Urology. 2009 Academic Article GET IT
Times cited: 14
Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma. BJU international. 2008 Academic Article GET IT
Times cited: 14
Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder. The Journal of urology. 2007 Academic Article GET IT
Times cited: 56